mPATH, a Winston-Salem, NC-based digital health company dedicated to improving cancer screening, raised $3M in funding.
The round consisted of $2M led by Small Business Technology Grant from the National Cancer Institute (NCI) and a $1M equity investment led by Oncology Ventures.
The company intends to use the funds to accelerate its growth and outreach efforts, allowing for the development of additional screening and preventive health modules.
The NCI grant, awarded in July 2024, will support the continued commercialization of mPATH’s cancer screening program. This grant will facilitate additional development and rigorous clinical testing of mPATH’s program.
Led by Dr. David Miller, mPATH Health is a digital health company dedicated to transforming preventive cancer screening by integrating automation and behavioral science. By leveraging technology and personalized outreach, it empowers individuals to prioritize their health and undergo regular screenings for early cancer detection.
FinSMEs
21/10/2024